(Q37015165)

17 August 2017

1 reference

title

Inflammation and oxidative stress in obstructive sleep apnea syndrome (English)

1 reference

17 August 2017

0 references

0 references

obstructive sleep apnea

1 reference

2

1 reference

17 August 2017

1

Carlo Selmi

1 reference

17 August 2017

5

M Eric Gershwin

1 reference

17 August 2017

4

Carl L Keen

1 reference

17 August 2017

Raffaello Furlan

3

1 reference

17 August 2017

publication date

1 December 2007

1 reference

Experimental Biology and Medicine

17 August 2017

published in

1 reference

17 August 2017

volume

232

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1409-1413

1 reference

Epidemiology of obstructive sleep apnea: a population health perspective

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Sympathetic neural mechanisms in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Obstructive sleep apnea, cardiovascular disease, and inflammation--is NF-kappaB the key?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Obstructive sleep apnoea syndrome--an oxidative stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Oxidative stress in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Association between lipid peroxidation and inflammation in obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Plasma homocysteine in obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Obstructive sleep apnea: implications for cardiac and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Circadian interleukin-6 secretion and quantity and depth of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Upper airway muscle inflammation and denervation changes in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Airway inflammation in patients affected by obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Antioxidant vitamin C improves endothelial function in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Inflamm-aging: autoimmunity, and the immune-risk phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Measuring nuclear factor-KB--who cares?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Gender as risk factor for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Mother-child immunological interactions in early life affect long-term humoral autoreactivity to heat shock protein 60 at age 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Cocoa extract protects against early alcohol-induced liver injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

The anti-inflammatory properties of cocoa flavanols

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

Pharmacogenomics and its implications for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0704-MR-103

21 January 2018

Identifiers

DOI

10.3181/0704-MR-103

1 reference

17 August 2017

1 reference